Filters

EphA8 (HEK3, EPA8, EEK, eph-, elk-related Tyrosine Kinase, Ephrin Receptor EphA8) Antibody

EphA8 (HEK3, EPA8, EEK, eph-, elk-related Tyrosine Kinase, Ephrin Receptor EphA8) Antibody size: 100ul 470

Price 470
Size 100ul
Alternative name1 EEK, EPA8, Ephrin Receptor EphA8), elk-related Tyrosine Kinase, eph-, Anti-EphA8 (HEK3
Alternative name2 EEK, EPA8, Ephrin Receptor EphA8), elk-related Tyrosine Kinase, eph-, EphA8 (HEK3
Alternative name3 EEK, EPA8, Ephrin Receptor EphA8), elk-related Tyrosine Kinase, eph-, EphA8 (HEK3
Alternative name4EphA8
Alternative name5 EEK, EPA8, Ephrin Receptor EphA8), elk-related Tyrosine Kinase, eph-, Anti -EphA8 (HEK3
Other names EK3, EPH receptor A8, EPH- and ELK-related kinase, EPH- and ELK-related kinase, EPH- and ELK-related tyrosine kinase, EPH-like kinase 3, EPH-like kinase 3, Ephrin type-A receptor 8, OTTHUMP00000002934, OTTHUMP00000002935, Tyrosine-protein kinase receptor EEK, ephrin type-A receptor 8, hEK3, hydroxyaryl-protein kinase, protein-tyrosine kinase, tyrosine-protein kinase receptor EEK, tyrosylprotein kinase, ephrin type-A receptor 8 isoform 1
Gene nameN/A
Gene name synonimsN/A
Other gene names EEK, EEK, EK3, EPHA8, HEK3, KIAA1459, KIAA1459, EPHA8
CategoryAntibodies
ClonalityPolyclonal
Immunoglobulin isotypeIgG
ClonePolyclonal antibody
Host organism Source: Human, Host: Rabbit
Species reactivity Mouse, Rat, Human
Specificity and cross-reactivity This sequence is 93% homologous in mouse and rat, Recognizes human HEK3
Purification methodPurified
Form/Appearance05% sodium azide, Rabbit sera and glycerol with 0
ConcentrationN/A
Storage and shipping Aliquots are stable for at least 12 months productone should be stored at -20 degrees Celsius, For long-term storage, For maximum recovery of product, For optimal long term storage, Further dilutions can be made in assay buffer, centrifuge the original vial after thawing and prior to removing the cap, productone should be kept at -20 degrees Celsius, Store at 4 degrees Celsius for short term storage
Tested for:ELISA (EL/EIA)
Description Polyclonal antibodies generally are more stable and retain their reactivity under unfavorable conditions, Polyclonal antibodies have series of advantages - larger batches can be supplied at a time, Properly used, To obtain more detailed information on productone, please, refer to the full product datasheet, the time needed for production is considerably shorter, they are inexpensive to manufacture and respectively to buy, this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, productone is a polyclonal antibody of high purity and binding affinity for the antigen that it is risen against
Advisory For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals_1 they should be stored frozen at - 24°
Gene target EEK, EPA8, Ephrin Receptor EphA8), eph elk-related Tyrosine Kinase, EphA8 (HEK3
Short name EEK, EPA8, Ephrin Receptor EphA8) Antibody, eph- elk-related Tyrosine Kinase, EphA8 (HEK3
Technique antibodies against human proteins, antibodies for, Antibody
Alternative name EEK, EPA8, Ephrin Receptor EphA8) (Antibody to), elk-related Tyrosine phosphorylation catalyst, eph-, EphA8 (HEK3
Alternative techniqueantibodies
Identity 3391
Gene EPHA8
Long gene name EPH receptor A8
Synonyms gene EEK
Synonyms gene name EphA8
Synonyms Hek3
Locus 1p36, 12
Discovery year 1990-09-30
GenBank acession BC038796
Entrez gene record 2046
Pubmed identfication 1648701
RefSeq identity NM_020526
Classification Sterile alpha motif domain containing Fibronectin type III domain containing EPH receptors
Havana BLAST/BLAT OTTHUMG00000002892

Subscribe to our Newsletter